Claim: Crisaborole is a nonsterodial topical medication, which are distinguished from corticosteroids as a class of anti-inflammatory agents.
Evidence: Crisaborole, sold under the brand name Eucrisa among others, is a nonsteroidal topical medication used for the treatment of mild-to-moderate atopic dermatitis (eczema) in adults and children. Nonsteroidal anti-inflammatory drugs (NSAIDs) are distinguished from corticosteroids as a class of anti-inflammatory agents.